Oric Pharmaceuticals (ORIC) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ORIC is expected to report earnings to rise 2.41% to -50 cents per share on March 25

Oric Pharmaceuticals ORIC Stock Earnings Reports

Q4'24

Est.

$-0.50

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.04

Q1'24

Beat

by $0.05

Q4'23

Missed

by $0.01

The last earnings report on November 12 showed earnings per share of -49 cents, missing the estimate of -47 cents. With 120.81K shares outstanding, the current market capitalization sits at 582.18M.

View a ticker or compare two or three

Compare

ORIC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ORIC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ORIC (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

240 E. Grand Avenue

Phone

+1 650 388-5600

Employees

100

Web